Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs

Janelle Applequist and Jennifer Gerard Ball
The Annals of Family Medicine May 2018, 16 (3) 211-216; DOI: https://doi.org/10.1370/afm.2220
Janelle Applequist
1Zimmerman School of Advertising and Mass Communications, University of South Florida, Tampa, Florida
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Gerard Ball
2Klein College of Media and Communication, Temple University, Philadelphia, Pennsylvania
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Published eLetters

If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

  • A Screenful of Sugar?
    Jon Schommer
    Published on: 24 May 2018
  • Time for Congress to act
    Dominick L. Frosch
    Published on: 16 May 2018
  • Published on: (24 May 2018)
    Page navigation anchor for A Screenful of Sugar?
    A Screenful of Sugar?
    • Jon Schommer, Professor

    Applequist and Ball provided an important update to their 2004 data regarding the types of content presented in prescription drug product claim ads.Their reference to Frosch's work (balancing policy with evidence in the regulation of prescription drug advertising) is outstanding and helps frame this important issue. My work with collaborator Lewis Glinert (Dartmouth College) that focuses upon prescription drug advertising...

    Show More

    Applequist and Ball provided an important update to their 2004 data regarding the types of content presented in prescription drug product claim ads.Their reference to Frosch's work (balancing policy with evidence in the regulation of prescription drug advertising) is outstanding and helps frame this important issue. My work with collaborator Lewis Glinert (Dartmouth College) that focuses upon prescription drug advertising on web sites benefits greatly from the work published by Applequist and Ball. Continued work that evaluates the content, oversight, organization, and language of prescription drug advertising will help frame decisions in this domain.

    Competing interests: I am co-author (with Lewis Glinert, Dartmouth College) for a book entitled "A Screenful of Sugar? Prescription Drug Websites Investigated."

    Show Less
    Competing Interests: None declared.
  • Published on: (16 May 2018)
    Page navigation anchor for Time for Congress to act
    Time for Congress to act
    • Dominick L. Frosch, Senior Scientist

    Congratulations to Dr. Applequist and Dr. Ball on a well-done and timely study. As a scientist I am proud to see our 2007 methods replicated with a recent sample of ads. As someone interested in more sensible health policy, I am troubled though, sadly, not surprised. In another paper we published on this topic in 2010 we wrote "DTCA amounts to a large and expensive uncontrolled experiment in population health, which to...

    Show More

    Congratulations to Dr. Applequist and Dr. Ball on a well-done and timely study. As a scientist I am proud to see our 2007 methods replicated with a recent sample of ads. As someone interested in more sensible health policy, I am troubled though, sadly, not surprised. In another paper we published on this topic in 2010 we wrote "DTCA amounts to a large and expensive uncontrolled experiment in population health, which to date shows decidedly mixed effects." The findings by Applequist and Ball don't spur much optimism that this situation has improved. The lack of funding for research on DTCA is one impediment. Lack of access to relevant data is another. Surely, the industry must know much more about the effects of this $6 billion/annually experiment it is funding than the public does. It is time for Congress to ask more probing questions. These new data call for it.

    Competing interests: None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 16 (3)
The Annals of Family Medicine: 16 (3)
Vol. 16, Issue 3
May/June 2018
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs
Janelle Applequist, Jennifer Gerard Ball
The Annals of Family Medicine May 2018, 16 (3) 211-216; DOI: 10.1370/afm.2220

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs
Janelle Applequist, Jennifer Gerard Ball
The Annals of Family Medicine May 2018, 16 (3) 211-216; DOI: 10.1370/afm.2220
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment
  • US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion
  • In This Issue: Sometimes More is Less
  • Google Scholar

More in this TOC Section

  • Teamwork Among Primary Care Staff to Achieve Regular Follow-Up of Chronic Patients
  • Shared Decision Making Among Racially and/or Ethnically Diverse Populations in Primary Care: A Scoping Review of Barriers and Facilitators
  • Convenience or Continuity: When Are Patients Willing to Wait to See Their Own Doctor?
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Acute illness
    • Chronic illness
  • Person groups:
    • Community / population health
  • Methods:
    • Qualitative methods
  • Other research types:
    • Health policy
  • Core values of primary care:
    • Access
    • Personalized care
  • Other topics:
    • Education
    • Social / cultural context
    • Disparities in health and health care
    • Communication / decision making

Keywords

  • prescription drug advertising
  • DTC
  • direct-to-consumer advertising
  • DTCA
  • content analysis
  • pharmaceutical industry

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine